People
Ulf Grundmann is Partner of the Government Matters Practice Group, and focuses on regulations and compliance regarding the pharmaceutical, medical devices, cosmetic and food industries, and on litigation in the European Union. For more than 25 years, Ulf has advised clients through all stages of the product life cycle, including product development, trademark clearance, labeling, advertising and promotion, product launch, distribution, licensing and compliance in the EU. He also handles all kinds of litigation related to the products, the distribution, intellectual property rights, competition and advertising. This includes aspects related to parallel imports, protection against falsified products, recalls, and product end-of-life. He litigates matters before German and European courts, including the General Court and the Court of Justice of the EU.
Ulf counsels clients in the European Union on regulatory, unfair competition and compliance laws, and represents clients before national and European authorities, including the European Commission. He also works with life science companies on corporate and financial transactions.
As frequent author, speaker and moderator at life sciences and food conferences, Ulf also serves as a lecturer at the Frankfurt School of Finance and Management as well as the DeutscheAnwaltsAkademie.
LMG Life Sciences EMEA 2022 named Ulf a "Parallel Import Lawyer of the Year". JUVE 2022/23 named him a "Leading Name" for pharmaceutical and medical devices law for the second year in a row. He has been recognized among Germany's leading lawyers for pharmaceuticals, medical devices and food law by publications such as JUVE, Legal 500, best lawyers and Who's Who Legal for many years.
Frankfurt
Frankfurt, Germany (Admitted 1/9/1995; Reg. # 127327)
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
January 19, 2023
EU Medicine Reboxing Ruling Gives Guidance To Pharma Cos.
January 10, 2023
MDD Certificates Remain Valid: European Commission Proposes Longer Transition Periods for MDR Compliance
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
January 19, 2023
EU Medicine Reboxing Ruling Gives Guidance To Pharma Cos.
January 10, 2023
MDD Certificates Remain Valid: European Commission Proposes Longer Transition Periods for MDR Compliance
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
Frankfurt
Frankfurt, Germany (Admitted 1/9/1995; Reg. # 127327)